Your session is about to expire
← Back to Search
AZD9833 + Palbociclib for Breast Cancer (SERENA-4 Trial)
SERENA-4 Trial Summary
This trial is testing whether a new drug combo is better than a current standard of care for treating a certain type of breast cancer.
SERENA-4 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSERENA-4 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SERENA-4 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I haven't received any systemic anti-cancer treatments for my ER+ recurrent or metastatic cancer.My breast cancer cannot be treated with surgery or radiation.My cancer has spread to my brain or spinal cord and is not under control.I do not have an active infection like TB, hepatitis B, or hepatitis C.My organs and bone marrow are working well.I am currently on cancer treatment or taking drugs that affect body proteins.I do not have any severe illnesses that would make it unsafe for me to join the study.I am willing and able to follow the study's schedule and procedures.My cancer can be measured by scans or I have a bone lesion that can be seen on CT or MRI.My cancer returned while on AI treatment or within 12 months after finishing it.I am willing to take hormone therapy if I am pre- or peri-menopausal or a man.I am fully active or restricted in physically strenuous activity but can do light work.I do not have major health issues like TB, HIV, heart problems, or a kidney transplant that could affect my trial participation.I have never had systemic therapy for advanced breast cancer.I can perform my daily activities without assistance.I do not have active brain metastases or related conditions.I have not taken AZD9833, fulvestrant, or similar experimental drugs.My cancer was diagnosed at stage 4 or came back after 2 years of hormone therapy.You had certain types of tumors in the past that the study doctors think could return.My cancer has spread to my organs and poses an immediate risk to my life.My cancer returned within a year after treatment.I am not currently receiving any cancer treatments.My breast cancer is ER+ and HER2-negative, confirmed by lab tests.My tumor is ER positive but does not have high levels of HER2.My breast cancer has spread or returned after 2 years of hormone therapy.I have heart disease that affects my daily life.
- Group 1: AZD9833 + palbociclib
- Group 2: Anastrozole + palbociclib
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is it presently possible to sign-up for this clinical trial?
"This trial is currently looking for participants. It was originally posted on January 28, 2021 and was last updated on October 26, 2022."
What other similar medical studies have there been for AZD9833?
"As of right now, there are 204 different clinical trials being conducted that involve AZD9833. 40 of those trials are in their third and final phase. Even though a large majority of the trials are based in Burgas, New jersey, there are actually 13885 total locations running these tests."
At how many different locations is this experiment being conducted presently?
"To make participating more convenient for patients, this trial is being conducted at 50 sites. Some of these locations include Pittsburgh, Solvang, and Omaha. However, there are many other locations across the country."
What are the common indications for AZD9833?
"While typically used to treat patients that have undergone 2-3 years of tamoxifen therapy, AZD9833 can also help patients suffering from hypogonadotropic ovarian failure, invasive early breast cancer, and female infertility."
Are the age restrictions for this trial flexible?
"This study is open to adults that are 18 years or older and have not yet reached their 130th birthday."
How many people total will be enrolled in this clinical trial?
"The data available on clinicaltrials.gov indicates that this is an ongoing study that is looking for 1342 patients from 50 different locations. This trial was first posted on 1/28/2021 and was most recently updated on 10/26/2021."
What is the latest update on the FDA's stance on AZD9833?
"AZD9833 is in Phase 3 clinical trials, so there is some evidence of its efficacy and multiple rounds of data supporting its safety, which our team at Power estimates to be a 3 on a scale from 1 to 3."
Are there any specific medical qualifications necessary to join this clinical trial?
"This clinical trial is recruiting 1342 participants with breast cancer who are between the ages of 18 and 130. The following are the inclusion criteria for this trial:-The breast cancer cannot be treated with surgery or radiation-The breast cancer has already spread to other parts of the body or has come back after at least 2 years of standard endocrine treatment-The tumors do not overexpress HER2 protein-The participants have never received any cancer therapy that affects the whole body for advanced breast cancer-The participants are able to do their daily activities-The participants are pre-/peri-men"
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger